In vitro synthesis of modified rna for cardiac gene therapy

8Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Modified mRNA (modRNA) is a promising new gene therapy approach that has safely and effectively delivered genes into different tissues, including the heart. Current efforts to use DNA-based or viral gene therapy to induce cardiac regeneration postmyocardial infarction (MI) or in heart failure (HF) have encountered key challenges, e.g., genome integration and delayed and noncontrolled expression. By contrast, modRNA is a transient, safe, non-immunogenic, and controlled gene delivery method that is not integrated into the genome. For most therapeutic applications, especially in regenerative medicine, the ability to deliver genes to the heart transiently and with control is vital for achieving therapeutic effect. Additionally, modRNA synthesis is comparatively simple and inexpensive compared to other gene delivery methods (e.g., protein), though a simple, clear in vitro transcription (IVT) protocol for synthesizing modRNA is needed for it to be more widely used. Here, we describe a simple and improved step-by-step IVT protocol to synthesize modRNA for in vitro or in vivo applications.

Cite

CITATION STYLE

APA

Sultana, N., Sharkar, M. T. K., Hadas, Y., Chepurko, E., & Zangi, L. (2021). In vitro synthesis of modified rna for cardiac gene therapy. In Methods in Molecular Biology (Vol. 2158, pp. 281–294). Humana Press Inc. https://doi.org/10.1007/978-1-0716-0668-1_21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free